Form 8-K - Current report:
SEC Accession No. 0001193125-24-222429
Filing Date
2024-09-20
Accepted
2024-09-20 07:00:58
Documents
13
Period of Report
2024-09-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d844965d8k.htm   iXBRL 8-K 109114
  Complete submission text file 0001193125-24-222429.txt   252714

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rphm-20240920.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rphm-20240920_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rphm-20240920_pre.xml EX-101.PRE 11716
15 EXTRACTED XBRL INSTANCE DOCUMENT d844965d8k_htm.xml XML 4071
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 241311664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)